137 related articles for article (PubMed ID: 37009820)
1. Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE.
Zhou H; Zhao X; Zhang R; Miao M; Pei W; Li Z; Li Y; He J; Li Z; Sun X
Signal Transduct Target Ther; 2023 Apr; 8(1):141. PubMed ID: 37009820
[No Abstract] [Full Text] [Related]
2. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus.
von Spee-Mayer C; Siegert E; Abdirama D; Rose A; Klaus A; Alexander T; Enghard P; Sawitzki B; Hiepe F; Radbruch A; Burmester GR; Riemekasten G; Humrich JY
Ann Rheum Dis; 2016 Jul; 75(7):1407-15. PubMed ID: 26324847
[TBL] [Abstract][Full Text] [Related]
3. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
[TBL] [Abstract][Full Text] [Related]
4. IL-6 alters migration capacity of CD4
He S; Xue M; Cai G
Scand J Immunol; 2021 Nov; 94(5):e13099. PubMed ID: 34940981
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor β.
Horwitz DA; Bickerton S; Koss M; Fahmy TM; La Cava A
Arthritis Rheumatol; 2019 Apr; 71(4):632-640. PubMed ID: 30407752
[TBL] [Abstract][Full Text] [Related]
6. Low-dose IL-2 therapy limits the reduction in absolute numbers of peripheral lymphocytes in systemic lupus erythematosus patients with infection.
Zhang JQ; Zhang SX; Wang J; Qiao J; Qiu MT; Wu XY; Chen JW; Gao C; Li XF
Curr Med Res Opin; 2022 Jun; 38(6):1037-1044. PubMed ID: 35414310
[TBL] [Abstract][Full Text] [Related]
7. Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus.
Comte D; Karampetsou MP; Kis-Toth K; Yoshida N; Bradley SJ; Mizui M; Kono M; Solomon JR; Kyttaris VC; Tsokos GC
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9321-6. PubMed ID: 27482100
[TBL] [Abstract][Full Text] [Related]
8. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants.
Barreto M; Ferreira RC; Lourenço L; Moraes-Fontes MF; Santos E; Alves M; Carvalho C; Martins B; Andreia R; Viana JF; Vasconcelos C; Mota-Vieira L; Ferreira C; Demengeot J; Vicente AM
BMC Immunol; 2009 Jan; 10():5. PubMed ID: 19173720
[TBL] [Abstract][Full Text] [Related]
9. [Abnormality and significance of interleukin-9 and CD4(+)interleukin-9(+) T-cells in peripheral blood of patients with systemic lupus erythematosus].
Ouyang H; Shi YB; Su N; Li LY
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):99-103. PubMed ID: 23648344
[TBL] [Abstract][Full Text] [Related]
10. Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus.
Engler JB; Undeutsch R; Kloke L; Rosenberger S; Backhaus M; Schneider U; Egerer K; Dragun D; Hofmann J; Huscher D; Burmester GR; Humrich JY; Enghard P; Riemekasten G
Ann Rheum Dis; 2011 Dec; 70(12):2176-83. PubMed ID: 21926188
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
12. Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.
He J; Zhang X; Wei Y; Sun X; Chen Y; Deng J; Jin Y; Gan Y; Hu X; Jia R; Xu C; Hou Z; Leong YA; Zhu L; Feng J; An Y; Jia Y; Li C; Liu X; Ye H; Ren L; Li R; Yao H; Li Y; Chen S; Zhang X; Su Y; Guo J; Shen N; Morand EF; Yu D; Li Z
Nat Med; 2016 Sep; 22(9):991-3. PubMed ID: 27500725
[TBL] [Abstract][Full Text] [Related]
13. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
14. [Effects of glucocorticoids on the expression of GTIR and apoptosis of the CD4(+)CD25(+)CD127(dim/-) T cells in patients with systemic lupus erythematosus].
Pan Y; Li XP; Sun JF; Wang L; Chen Z; Li XM; Tao JH; Qian L; Zhang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):215-20. PubMed ID: 22516990
[TBL] [Abstract][Full Text] [Related]
15. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
Guo Q; Chen XY; Su Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
[TBL] [Abstract][Full Text] [Related]
16. Expansion of regulatory T cells using low-dose interleukin-2 attenuates hypertension in an experimental model of systemic lupus erythematosus.
Taylor EB; Sasser JM; Maeda KJ; Ryan MJ
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1274-F1284. PubMed ID: 30892934
[TBL] [Abstract][Full Text] [Related]
17. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
18. CD(+)(4)CD(+)(25) Treg cells in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus patients.
Huang H; Sun W; Liang Y; Long XD; Peng Y; Liu Z; Wen X; Jia M
Ren Fail; 2014 Sep; 36(8):1263-7. PubMed ID: 24990576
[TBL] [Abstract][Full Text] [Related]
19. Increased Set1 binding at the promoter induces aberrant epigenetic alterations and up-regulates cyclic adenosine 5'-monophosphate response element modulator alpha in systemic lupus erythematosus.
Zhang Q; Ding S; Zhang H; Long H; Wu H; Zhao M; Chan V; Lau CS; Lu Q
Clin Epigenetics; 2016; 8():126. PubMed ID: 27904655
[TBL] [Abstract][Full Text] [Related]
20. Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp
Ferreira RC; Castro Dopico X; Oliveira JJ; Rainbow DB; Yang JH; Trzupek D; Todd SA; McNeill M; Steri M; Orrù V; Fiorillo E; Crouch DJM; Pekalski ML; Cucca F; Tree TI; Vyse TJ; Wicker LS; Todd JA
Front Immunol; 2019; 10():2606. PubMed ID: 31781109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
